Success Stories: Chinese Scientist in Biochemistry gets O1A Approval with NAILG’S Help in Just 8 Days With Premium Processing
Client’s Testimonial:
“It is really exciting news and thanks again for your efforts to make this happen.”
On September 3rd, 2021, we received another O1-A (Individuals with Extraordinary Ability or Achievement) approval for a Scientist in the Field of Biochemistry (Approval Notice).
General Field: Biochemistry
Position at the Time of Case Filing: Scientist
Country of Origin: China
State of Residence at the Time of Filing: Washington
Approval Notice Date: September 3rd, 2021
Processing Time: 8 days (Premium Processing Requested)
Case Summary:
The very competitive criteria set by USCIS for qualification under the O1A (Extraordinary Ability) category is tough to qualify to say the least. The plain language demands that any applicant prove beyond doubt their ability to uphold the markers of the O1A category. In August of 2020, a scientist in biochemistry with a Ph.D. in pharmacology approached us to help him get an O1A approval. So, first, we made sure that he understood the meaning of the criteria clearly, and then moved on to explain to him the next steps involving a detailed case study followed by petition preparation.
Our team then made sure that he received the best service possible and used information from his professional and academic background to build a solid case in his favor. The petition packet thus included his citation record, his publication count, and his review experience. This was aided by letters of recommendation that our client was able to obtain on our suggestion, quotes from two of which are used below to indicate the invaluable work that he has done for the United States and the field of biochemistry.
“Due to the number of Americans who are diagnosed with these cancers annually and the relatively low survival rates of both, it is crucial that we identify better approaches with which to prevent and treat these cancers. [Our client] a researcher in biochemistry, has worked to understand the underlying factors responsible for the development of these cancers. His research offers new targets by which to identify and treat cancer at earlier stages, thus improving patient outcomes in the United States.”
“He has made profound investigations into the critical mechanisms of liver and pancreas carcinogenesis, critical areas of scientific research that are invaluable to medical progression and upholding public health. As such, I have no doubt that [clients] future contributions to the field will continue to advance the field in fundamental ways.”
He also has an extensively documented record of authorship in his field of endeavor. As evidence of this research success, his work has resulted in 4 peer-reviewed scientific articles. His work has been published in some of the most prestigious, high-impact journals in his field. Moreover, his work has been cited 33 times in other peer-reviewed journal articles according to Google Scholar. He has also conducted 7 reviews. Only top-level experts in their field are invited to perform this important review work, so this frequent review activity further demonstrates his important standing in the field.
All of these facts, when put together, made for a very convincing application leading our client to success. We are happy to have had the opportunity to help him in this process and get his O1A approval in just 8 days due to premium processing.